0
Skip to Content
OrganoTherapeutics
Home
The Science
Technology
About us
News
Contact | FAQ
OrganoTherapeutics
Home
The Science
Technology
About us
News
Contact | FAQ
Home
The Science
Technology
About us
News
Contact | FAQ
Endogenous accumulation of alpha-synuclein in microglia-containing organoids; a new research breakthrough
Sònia Sabate 7/31/25 Sònia Sabate 7/31/25

Endogenous accumulation of alpha-synuclein in microglia-containing organoids; a new research breakthrough

Read More
OrganoTherapeutics Newsletter June 2025 ; Altered mtDNA dynamics and neurodegeneration in organoids
Sònia Sabate 7/7/25 Sònia Sabate 7/7/25

OrganoTherapeutics Newsletter June 2025 ; Altered mtDNA dynamics and neurodegeneration in organoids

Read More
OrganoTherapeutics and molmir Announce Strategic Collaboration to Accelerate Neurodegenerative Disease Research
Sònia Sabate 7/1/25 Sònia Sabate 7/1/25

OrganoTherapeutics and molmir Announce Strategic Collaboration to Accelerate Neurodegenerative Disease Research

Read More
OrganoTherapeutics Newsletter - May 2025 ; Reproducibility of PD patient-specific midbrain organoid data
Sònia Sabate 6/30/25 Sònia Sabate 6/30/25

OrganoTherapeutics Newsletter - May 2025 ; Reproducibility of PD patient-specific midbrain organoid data

Read More
OrganoTherapeutics Joins Michael J. Fox Foundation’s LRRK2 Therapeutics Exchange with midbrain organoid systems
Sònia Sabate 4/24/25 Sònia Sabate 4/24/25

OrganoTherapeutics Joins Michael J. Fox Foundation’s LRRK2 Therapeutics Exchange with midbrain organoid systems

Read More
OrganoTherapeutics Newsletter - April 2025 ; Assessment and quantification of dopaminergic neurite fragmentation
Sònia Sabate 4/23/25 Sònia Sabate 4/23/25

OrganoTherapeutics Newsletter - April 2025 ; Assessment and quantification of dopaminergic neurite fragmentation

Read More
Advancing reproducibility in organoid research: a breakthrough for midbrain models
Sònia Sabate 4/22/25 Sònia Sabate 4/22/25

Advancing reproducibility in organoid research: a breakthrough for midbrain models

Read More
FDA's shift from animal testing: unlocking the potential of midbrain organoids in drug development​
Sònia Sabate 4/17/25 Sònia Sabate 4/17/25

FDA's shift from animal testing: unlocking the potential of midbrain organoids in drug development​

Read More
OrganoTherapeutics Newsletter - March 2025 ; Neurofilament light release  in organoids
Sònia Sabate 3/31/25 Sònia Sabate 3/31/25

OrganoTherapeutics Newsletter - March 2025 ; Neurofilament light release in organoids

Read More
OrganoTherapeutics Newsletter - February 2025 ; 3D tissue clearing for advanced imaging
Sònia Sabate 3/26/25 Sònia Sabate 3/26/25

OrganoTherapeutics Newsletter - February 2025 ; 3D tissue clearing for advanced imaging

Read More
Successful Project Collaboration with Animal Free Research UK: united for animal-free research
Sònia Sabate 3/12/25 Sònia Sabate 3/12/25

Successful Project Collaboration with Animal Free Research UK: united for animal-free research

Read More
The move of OrganoTherapeutics: Welcome to our new fully-equipped laboratory spaces in Luxembourg
Sònia Sabate 12/10/24 Sònia Sabate 12/10/24

The move of OrganoTherapeutics: Welcome to our new fully-equipped laboratory spaces in Luxembourg

Read More
OrganoTherapeutics and mo:re join forces on the development of organoid culture automation
Sònia Sabate 1/25/24 Sònia Sabate 1/25/24

OrganoTherapeutics and mo:re join forces on the development of organoid culture automation

Read More
The Autonomous University of Barcelona and OrganoTherapeutics collaborate on Parkinson’s Disease therapeutics
Sònia Sabate 1/18/24 Sònia Sabate 1/18/24

The Autonomous University of Barcelona and OrganoTherapeutics collaborate on Parkinson’s Disease therapeutics

Read More
New collaboration between OrganoTherapeutics and Juntendo for the transfer of PD patient samples
Sònia Sabate 11/30/23 Sònia Sabate 11/30/23

New collaboration between OrganoTherapeutics and Juntendo for the transfer of PD patient samples

Read More
New collaboration: OrganoTherapeutics and StressMarq Biosciences join forces for alpha-synuclein pathology research
Sònia Sabate 10/26/23 Sònia Sabate 10/26/23

New collaboration: OrganoTherapeutics and StressMarq Biosciences join forces for alpha-synuclein pathology research

Read More

OrganoTherapeutics SARL

Home

The Science

Technology

About us

News

Contact

Contact us

adam.smith@organo-therapeutics.com

29 Rue Henri Koch. 4354 Esch-sur-Alzette (Luxembourg)

Linkedin